{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T08:25:53Z","timestamp":1758702353174,"version":"3.38.0"},"reference-count":84,"publisher":"JLE","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.nephro.2017.06.005","type":"journal-article","created":{"date-parts":[[2017,12,20]],"date-time":"2017-12-20T14:11:14Z","timestamp":1513779074000},"page":"S115-S124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"S1","title":["Inhibiteurs de la pompe \u00e0 protons et rein"],"prefix":"10.1684","volume":"14","author":[{"given":"Geoffroy","family":"Desbuissons","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilbert","family":"Deray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucile","family":"Mercadal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.nephro.2017.06.005_bib0005","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-2036.1994.tb00265.x","article-title":"Safety of proton pump inhibitors \u2013\u00a0an overview","volume":"8","author":"Arnold","year":"1994","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.nephro.2017.06.005_bib0010","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/0002-9343(92)90181-A","article-title":"Acute interstitial nephritis due to omeprazole","volume":"93","author":"Ruffenach","year":"1992","journal-title":"Am J Med"},{"key":"10.1016\/j.nephro.2017.06.005_bib0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5009\/gnl15502","article-title":"25\u00a0years of proton pump inhibitors: a comprehensive review","volume":"11","author":"Strand","year":"2017","journal-title":"Gut Liver"},{"year":"2009","series-title":"Les inhibiteurs de la pompe \u00e0 protons chez l\u2019adulte. Bon usage du m\u00e9dicament","author":"Haute Autorit\u00e9 de sant\u00e9","key":"10.1016\/j.nephro.2017.06.005_bib0020"},{"key":"10.1016\/j.nephro.2017.06.005_bib0025","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJM199510263331703","article-title":"A comparison of five maintenance therapies for reflux esophagitis","volume":"333","author":"Vigneri","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2017.06.005_bib0030","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2036.2010.04511.x","article-title":"Randomised clinical trial: high-dose acid suppression for chronic cough \u2013\u00a0a double-blind, placebo-controlled study","volume":"33","author":"Shaheen","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.nephro.2017.06.005_bib0035","doi-asserted-by":"crossref","first-page":"e5149","DOI":"10.1590\/1414-431X20165149","article-title":"Meta-analysis of the efficacy of proton pump inhibitors for the symptoms of laryngopharyngeal reflux","volume":"49","author":"Liu","year":"2016","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.nephro.2017.06.005_bib0040","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJM199803123381104","article-title":"A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group","volume":"338","author":"Yeomans","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2017.06.005_bib0045","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1056\/NEJM198901123200201","article-title":"Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer","volume":"320","author":"Walan","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2017.06.005_bib0050","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.dld.2010.11.007","article-title":"Zollinger-Ellison syndrome: presentation, response to therapy and outcome","volume":"43","author":"Wilcox","year":"2011","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.nephro.2017.06.005_bib0055","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3109\/0886022X.2011.560407","article-title":"Prophylactic use of omeprazole associated with a reduced risk of peptic ulcer disease among maintenance hemodialysis patients","volume":"33","author":"Liang","year":"2011","journal-title":"Ren Fail"},{"key":"10.1016\/j.nephro.2017.06.005_bib0060","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2369-14-15","article-title":"The risk of upper gastrointestinal bleeding in patients treated with hemodialysis: a population-based cohort study","volume":"14","author":"Kuo","year":"2013","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.nephro.2017.06.005_bib0065","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.3748\/wjg.v21.i16.4919","article-title":"Proton-pump inhibitors for prevention of upper gastrointestinal bleeding in patients undergoing dialysis","volume":"21","author":"Song","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.nephro.2017.06.005_bib0070","first-page":"347","article-title":"ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on November 14, 1998","volume":"56","author":"Therapeutic Guidelines on Stress Ulcer Prophylaxis ASHP","year":"1999","journal-title":"Am J Health-Syst Pharm"},{"key":"10.1016\/j.nephro.2017.06.005_bib0075","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s13063-016-1331-3","article-title":"Stress ulcer prophylaxis with a proton pump inhibitor versus placebo in critically ill patients (SUP-ICU trial): study protocol for a randomised controlled trial","volume":"17","author":"Krag","year":"2016","journal-title":"Trials"},{"key":"10.1016\/j.nephro.2017.06.005_bib0080","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/bmj.39406.449456.BE","article-title":"Overprescribing proton pump inhibitors","volume":"336","author":"Forgacs","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.nephro.2017.06.005_bib0085","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.1365-2710.2000.00312.x","article-title":"Overuse of proton pump inhibitors","volume":"25","author":"Naunton","year":"2000","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.nephro.2017.06.005_bib0090","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1742-1241.2004.00298.x","article-title":"Proton pump inhibitors: a survey of prescribing in an Irish general hospital","volume":"59","author":"Mat Saad","year":"2005","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.nephro.2017.06.005_bib0095","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1023\/A:1011278030001","article-title":"An evaluation of the use of proton pump inhibitors","volume":"23","author":"Walker","year":"2001","journal-title":"Pharm World Sci"},{"key":"10.1016\/j.nephro.2017.06.005_bib0100","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/jhm.1901","article-title":"Inappropriate prescribing of proton pump inhibitors in hospitalized patients","volume":"7","author":"Reid","year":"2012","journal-title":"J Hosp Med"},{"key":"10.1016\/j.nephro.2017.06.005_bib0105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11096-006-9028-4","article-title":"Continuation of proton pump inhibitors from hospital to community","volume":"28","author":"Grant","year":"2006","journal-title":"Pharm World Sci"},{"key":"10.1016\/j.nephro.2017.06.005_bib0110","first-page":"383","article-title":"Appropriate proton pump inhibitors use in elderly outpatients according to recommendations","volume":"14","author":"Schonheit","year":"2016","journal-title":"Geriatr Psychol Neuropsychiatr Vieil"},{"key":"10.1016\/j.nephro.2017.06.005_bib0115","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/MPG.0b013e3182a3b04e","article-title":"Changes in prescription patterns of acid-suppressant medications by Belgian pediatricians: analysis of the national database [1997\u20132009]","volume":"58","author":"De Bruyne","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"Suppl. 1","key":"10.1016\/j.nephro.2017.06.005_bib0120","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000200107","article-title":"Omeprazole: long-term safety","volume":"44","author":"Arnold","year":"1989","journal-title":"Digestion"},{"key":"10.1016\/j.nephro.2017.06.005_bib0125","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.296.24.2947","article-title":"Long-term proton pump inhibitor therapy and risk of hip fracture","volume":"296","author":"Yang","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.nephro.2017.06.005_bib0130","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00198-015-3365-x","article-title":"Proton-pump inhibitors and risk of fractures: an update meta-analysis","volume":"27","author":"Zhou","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.nephro.2017.06.005_bib0135","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1053\/j.ajkd.2016.09.019","article-title":"Proton pump inhibitor use and risk of hip fracture in kidney transplant recipients","volume":"69","author":"Lenihan","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2017.06.005_bib0140","doi-asserted-by":"crossref","first-page":"e0128004","DOI":"10.1371\/journal.pone.0128004","article-title":"Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis","volume":"10","author":"Lambert","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.nephro.2017.06.005_bib0145","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jmii.2013.10.004","article-title":"Proton pump inhibitor usage and the associated risk of pneumonia in patients with chronic kidney disease","volume":"48","author":"Chen","year":"2015","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.nephro.2017.06.005_bib0150","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1080\/14740338.2016.1238071","article-title":"Proton pump inhibitors and risk of Clostridium difficile infection: a multi-country study using sequence symmetry analysis","volume":"15","author":"Roughead","year":"2016","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.nephro.2017.06.005_bib0155","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/ajg.2012.108","article-title":"Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis","volume":"107","author":"Kwok","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.nephro.2017.06.005_bib0160","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/ajg.2012.179","article-title":"Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis","volume":"107","author":"Janarthanan","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.nephro.2017.06.005_bib0165","doi-asserted-by":"crossref","first-page":"e56498","DOI":"10.1371\/journal.pone.0056498","article-title":"The association between histamine 2\u00a0receptor antagonist use and Clostridium difficile infection: a systematic review and meta-analysis","volume":"8","author":"Tleyjeh","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.nephro.2017.06.005_bib0170","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/jama.2009.261","article-title":"Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome","volume":"301","author":"Ho","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.nephro.2017.06.005_bib0175","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jacc.2007.06.064","article-title":"Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (omeprazole clopidogrel aspirin) study","volume":"51","author":"Gilard","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nephro.2017.06.005_bib0180","doi-asserted-by":"crossref","first-page":"e0124653","DOI":"10.1371\/journal.pone.0124653","article-title":"Proton pump inhibitor usage and the risk of myocardial infarction in the general population","volume":"10","author":"Shah","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.nephro.2017.06.005_bib0185","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jamaneurol.2015.4791","article-title":"Association of proton pump inhibitors with risk of dementia: a pharmacoepidemiological claims data analysis","volume":"73","author":"Gomm","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.nephro.2017.06.005_bib0190","first-page":"845","article-title":"Use of proton pump inhibitors and the risk of listeriosis. A nationwide registry-based case-control study","volume":"64","author":"Kvistholm Jensen","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.nephro.2017.06.005_bib0195","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3109\/09537104.2014.953045","article-title":"Proton pump induced thrombocytopenia: a case report and review of literature","volume":"26","author":"Kallam","year":"2015","journal-title":"Platelets"},{"key":"10.1016\/j.nephro.2017.06.005_bib0200","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1001\/jama.2013.280490","article-title":"Proton pump inhibitor and histamine 2-receptor antagonist use and vitamin B12\u00a0deficiency","volume":"310","author":"Lam","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.nephro.2017.06.005_bib0205","first-page":"157","article-title":"New frequent adverse reaction of PPI in older adults: mild hyponatremia","volume":"69","author":"Peyro Saint-Paul","year":"2014","journal-title":"Therapie"},{"key":"10.1016\/j.nephro.2017.06.005_bib0210","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/pds.1795","article-title":"Uses of proton pump inhibitors and serum potassium levels","volume":"18","author":"Gau","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.nephro.2017.06.005_bib0215","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1001\/jamainternmed.2013.2851","article-title":"Proton pump inhibitors and risk of 1-year mortality and rehospitalization in older patients discharged from acute care hospitals","volume":"173","author":"Maggio","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.nephro.2017.06.005_bib0220","first-page":"488","article-title":"Risk of death associated with use of PPIs in three cohorts of institutionalized older people in Finland","volume":"13","author":"Teramura-Gr\u00f6nblad","year":"2012","journal-title":"J Am Med"},{"key":"10.1016\/j.nephro.2017.06.005_bib0225","first-page":"580","article-title":"Pantoprazole-induced acute interstitial nephritis","volume":"17","author":"Moore","year":"2004","journal-title":"J Nephrol"},{"key":"10.1016\/j.nephro.2017.06.005_bib0230","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.revmed.2008.02.001","article-title":"Rabeprazole induced acute interstitial nephritis","volume":"29","author":"Baudeau","year":"2008","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.nephro.2017.06.005_bib0235","doi-asserted-by":"crossref","first-page":"304","DOI":"10.4103\/0971-4065.114487","article-title":"Acute interstitial nephritis due to proton pump inhibitors","volume":"23","author":"Sampathkumar","year":"2013","journal-title":"Indian J Nephrol"},{"key":"10.1016\/j.nephro.2017.06.005_bib0240","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/SMJ.0b013e318191e77c","article-title":"Lansoprazole-induced acute interstitial nephritis","volume":"102","author":"Eken","year":"2009","journal-title":"South Med J"},{"key":"10.1016\/j.nephro.2017.06.005_bib0245","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1007\/s11255-011-9972-3","article-title":"Lansoprazole-induced acute allergic interstitial nephritis in a renal transplant recipient: a case report","volume":"44","author":"Yildirim","year":"2012","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.nephro.2017.06.005_bib0250","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1111\/j.1572-0241.2001.05345.x","article-title":"Acute interstitial nephritis due to omeprazole","volume":"96","author":"Myers","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.nephro.2017.06.005_bib0255","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/ndt\/gfh137","article-title":"Drug-induced tubulo-interstitial nephritis secondary to proton pump inhibitors: experience from a single UK renal unit","volume":"19","author":"Torpey","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2017.06.005_bib0260","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1440-1797.2006.00651.x","article-title":"Proton pump inhibitors and acute interstitial nephritis: report and analysis of 15\u00a0cases","volume":"11","author":"Simpson","year":"2006","journal-title":"Nephrol Carlton Vic"},{"key":"10.1016\/j.nephro.2017.06.005_bib0265","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.cgh.2005.11.004","article-title":"Proton pump inhibitors and acute interstitial nephritis","volume":"4","author":"Geevasinga","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.nephro.2017.06.005_bib0270","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2036.2007.03407.x","article-title":"Systematic review: proton pump inhibitor-associated acute interstitial nephritis","volume":"26","author":"Sierra","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.nephro.2017.06.005_bib0275","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1365-2125.2007.02927.x","article-title":"Proton pump inhibitor-induced acute interstitial nephritis","volume":"64","author":"H\u00e4rmark","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.nephro.2017.06.005_bib0280","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/nep.12226","article-title":"Omeprazole-induced acute interstitial nephritis: a possible Th1-Th17-mediated injury?","volume":"19","author":"Berney-Meyer","year":"2014","journal-title":"Nephrol Carlton Vic"},{"key":"10.1016\/j.nephro.2017.06.005_bib0285","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1053\/j.ajkd.2014.04.027","article-title":"Biopsy-proven acute interstitial nephritis, 1993\u20132011: a case series","volume":"64","author":"Muriithi","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2017.06.005_bib0290","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1471-2369-14-150","article-title":"Proton pump inhibitors and acute kidney injury: a nested case-control study","volume":"14","author":"Klepser","year":"2013","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.nephro.2017.06.005_bib0295","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/ki.2014.74","article-title":"A nationwide nested case-control study indicates an increased risk of acute interstitial nephritis with proton pump inhibitor use","volume":"86","author":"Blank","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2017.06.005_bib0300","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/pds.3329","article-title":"Proton pump inhibitors and traditional nonsteroidal anti-inflammatory drugs and the risk of acute interstitial nephritis and acute kidney injury","volume":"21","author":"Leonard","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.nephro.2017.06.005_bib0305","doi-asserted-by":"crossref","first-page":"E166","DOI":"10.9778\/cmajo.20140074","article-title":"Proton pump inhibitors and the risk of acute kidney injury in older patients: a population-based cohort study","volume":"3","author":"Antoniou","year":"2015","journal-title":"CMAJ Open"},{"key":"10.1016\/j.nephro.2017.06.005_bib0310","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jamainternmed.2015.7193","article-title":"Proton pump inhibitor use and the risk of chronic kidney disease","volume":"176","author":"Lazarus","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.nephro.2017.06.005_bib0315","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.2147\/DDDT.S130568","article-title":"Proton-pump inhibitors use, and risk of acute kidney injury: a meta-analysis of observational studies","volume":"11","author":"Yang","year":"2017","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.nephro.2017.06.005_bib0320","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1681\/ASN.2015121377","article-title":"Proton pump inhibitors and risk of incident CKD and progression to ESRD","volume":"27","author":"Xie","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2017.06.005_bib0325","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.kint.2016.12.021","article-title":"Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury","volume":"91","author":"Xie","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2017.06.005_bib0330","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12882-016-0325-4","article-title":"Proton pump inhibitors are associated with increased risk of development of chronic kidney disease","volume":"17","author":"Arora","year":"2016","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.nephro.2017.06.005_bib0335","article-title":"The association between proton pump inhibitor use and the risk of adverse kidney outcomes: a systematic review and meta-analysis","author":"Nochaiwong","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2017.06.005_bib0340","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1001\/jamainternmed.2016.1857","article-title":"Adverse effects of proton pump inhibitors in chronic kidney disease","volume":"176","author":"Ness-Jensen","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.nephro.2017.06.005_bib0345","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1046\/j.1523-1755.2001.060002804.x","article-title":"Drug-induced acute interstitial nephritis","volume":"60","author":"Rossert","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2017.06.005_bib0350","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/ki.2010.89","article-title":"Acute interstitial nephritis","volume":"77","author":"Praga","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2017.06.005_bib0355","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/ki.2011.379","article-title":"Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis","volume":"81","author":"Coca","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2017.06.005_bib0360","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/ki.2012.462","article-title":"Proton pump inhibitors and hypomagnesemia: a rare but serious complication","volume":"83","author":"Perazella","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2017.06.005_bib0365","doi-asserted-by":"crossref","first-page":"e112558","DOI":"10.1371\/journal.pone.0112558","article-title":"The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis","volume":"9","author":"Park","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.nephro.2017.06.005_bib0370","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/ki.2014.331","article-title":"Results from the atherosclerosis risk in communities study suggest that low serum magnesium is associated with incident kidney disease","volume":"87","author":"Tin","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2017.06.005_bib0375","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2337\/dc12-0226","article-title":"Hypomagnesemia in type 2\u00a0diabetic nephropathy: a novel predictor of end-stage renal disease","volume":"35","author":"Sakaguchi","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.nephro.2017.06.005_bib0380","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1093\/ndt\/gfs126","article-title":"Hypomagnesaemia, the kidney and the vessels","volume":"27","author":"Van Laecke","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2017.06.005_bib0385","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1161\/CIRCRESAHA.116.308807","article-title":"Proton pump inhibitors accelerate endothelial senescence","volume":"118","author":"Yepuri","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.nephro.2017.06.005_bib0390","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s00535-013-0774-5","article-title":"Inhibition of lysosomal enzyme activities by proton pump inhibitors","volume":"48","author":"Liu","year":"2013","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.nephro.2017.06.005_bib0395","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1161\/CIRCRESAHA.116.309157","article-title":"Letter by Marlicz et al. Regarding article. \u201cProton pump inhibitors accelerate endothelial senescence.\u201d","volume":"119","author":"Marlicz","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.nephro.2017.06.005_bib0400","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gutjnl-2015-310861","article-title":"Proton pump inhibitors alter the composition of the gut microbiota","volume":"65","author":"Jackson","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.nephro.2017.06.005_bib0405","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/jamainternmed.2016.1854","article-title":"Adverse effects of proton pump inhibitors in chronic kidney disease","volume":"176","author":"Poesen","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.nephro.2017.06.005_bib0410","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1161\/CIRCRESAHA.114.305680","article-title":"TMAO is both a biomarker and a renal toxin","volume":"116","author":"Fogelman","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.nephro.2017.06.005_bib0415","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/CIRCRESAHA.116.305360","article-title":"Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease","volume":"116","author":"Tang","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.nephro.2017.06.005_bib0420","first-page":"526932","article-title":"P-cresyl sulfate is a valuable predictor of clinical outcomes in pre-ESRD patients","volume":"2014","author":"Lin","year":"2014","journal-title":"BioMed Res Int"}],"container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725517305849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725517305849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2017.06.005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:09:01Z","timestamp":1741190941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725517305849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":84,"alternative-id":["S1769725517305849"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2017.06.005","relation":{},"ISSN":["1769-7255"],"issn-type":[{"type":"print","value":"1769-7255"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibiteurs de la pompe \u00e0 protons et rein","name":"articletitle","label":"Article Title"},{"value":"N\u00e9phrologie & Th\u00e9rapeutique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nephro.2017.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Soci\u00e9t\u00e9 francophone de n\u00e9phrologie, dialyse et transplantation. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}